Veeva for Pharma:
Why Life Sciences Companies Are Moving to Vault CRM in 2026
– SmallBiz CRM Staff – 25th August, 2026
Veeva CRM has evolved. For pharmaceutical and life sciences companies, Vault CRM is becoming a strategic platform for connecting customer engagement, data, compliance and AI.
For many businesses, choosing a CRM means comparing familiar features: contact management, sales pipelines, email automation, reporting and integrations.
Pharmaceutical companies have a very different challenge.
Their customer relationships are complex. Field teams interact with healthcare professionals (HCPs), medical teams need access to relevant information, marketers coordinate multiple channels, and commercial activities must operate within strict regulatory requirements. At the same time, pharmaceutical companies face constant pressure to improve engagement, use data better, and give field teams more time to focus on customers.
That is where Veeva Vault CRM stands apart.
Rather than adapting a general-purpose CRM to life sciences requirements, Veeva built Vault CRM specifically around the industry’s commercial and medical processes.
And in 2026, the story is increasingly about more than CRM.
It is about AI, connected data, compliant customer engagement and turning information from the field into commercially useful evidence.
Veeva reported in March 2026 that more than 125 customers were already live on Vault CRM, including multiple top-20 biopharma companies. By August, Veeva was reporting more than 150 customers live on the platform.
So, why is Veeva attracting so much attention in the pharmaceutical industry?
A pharmaceutical sales representative does not have the same requirements as a salesperson selling office equipment or software.
A pharma field team may need to manage relationships with physicians, healthcare organisations and other HCPs, work with approved content, coordinate visits, record interactions, manage samples and operate across multiple channels.
Medical and commercial teams may also need to collaborate around the same customer while maintaining appropriate boundaries and compliance.
A conventional CRM can potentially be configured to support some of these activities. The problem is that configuration, integration and ongoing maintenance can become complicated.
Veeva takes a different approach.
Vault CRM is designed specifically for life sciences, bringing sales, marketing and medical teams together around a unified customer database and supporting industry-specific workflows, compliance requirements and regional needs. It also provides offline access for field teams working on iPads and iPhones.
That industry focus is one of Veeva’s biggest advantages.
Veeva Vault CRM: Built for the Pharmaceutical Industry
Vault CRM is part of the wider Veeva Vault CRM Suite, which brings together capabilities covering customer engagement, field activity, marketing, medical engagement and other commercial processes.
Its capabilities include:
- Customer profiling
- Territory and account planning
- Key account management
- Field engagement
- Sampling
- Approved email
- Digital engagement
- Events management
- Campaign management
- Service Center
- Mobile and offline access
- AI-powered assistance
- Compliance-focused workflows
The result is a CRM environment designed around the way life sciences organisations actually operate rather than a generic CRM with pharmaceutical features added later.
And that distinction matters.
One Customer View Across Teams
One of the recurring problems in large organisations is fragmented customer information.
Sales may have one view of an HCP. Marketing may have another. Medical teams may have additional information and interaction history.
Vault CRM is designed to bring these teams onto a shared platform and unified data foundation.
Veeva describes this as providing a single view of the customer, helping commercial and medical teams coordinate engagement and work from the same underlying information.
Ionis Pharmaceuticals’ Senior Vice President and Head of Information Technology, Parag Govil, summed up the importance of this approach:
“Vault CRM provides a connected data ecosystem for commercial and medical teams, centered on the customer.”
That is more than a convenient CRM feature.
For a global pharmaceutical company, having customer information connected across functions can become an important part of the organisation’s commercial infrastructure.
Compliance Is Not an Afterthought
Perhaps one of Veeva’s strongest arguments for pharmaceutical companies is compliance.
Pharma companies cannot simply treat customer data, promotional content and field interactions in the same way as an ordinary commercial organisation.
Vault CRM incorporates industry-specific compliance capabilities and supports region-specific business and regulatory requirements. Veeva says the platform is pre-validated for requirements including 21 CFR Part 11 and the Prescription Drug Marketing Act.
That does not mean every organisation can simply install Vault CRM and forget about compliance. Companies still need appropriate processes, configuration and governance.
But having compliance considerations built into the platform can reduce the need to construct everything from scratch.
For pharmaceutical organisations operating across multiple markets, that can be a significant advantage.
From CRM to AI-Powered Engagement
This is where Veeva’s 2026 story becomes particularly interesting.
Vault CRM is increasingly being positioned as an agentic CRM, with Veeva embedding industry-specific AI into the platform.
The aim is not simply to add a chatbot to CRM.
Veeva is using AI to help field teams prepare for interactions, find relevant information, capture notes and identify potentially useful insights from customer conversations.
Current capabilities include AI-powered pre-call preparation, media search, voice interaction and the Agentic Call Report.
For a busy pharmaceutical representative, that could mean less time spent navigating systems and entering information and more time concentrating on the actual customer interaction.
Bristol Myers Squibb’s Executive Vice President and Chief Digital and Technology Officer, Greg Meyers, puts the idea particularly well:
“Vault CRM and Veeva AI agents like Pre-call Agent and Voice Agent will drive efficiencies and allow the field to focus on the value parts of their jobs.”
That is an important distinction.
The objective is not AI for the sake of AI.
The objective is to remove administrative friction.
The Agentic Call Report: Turning Field Conversations Into Intelligence
One of Veeva’s more interesting developments is the Agentic Call Report.
Traditional CRM systems often rely heavily on structured fields. A representative completes a form, selects options from dropdown menus and records notes.
That produces useful data, but potentially valuable information can be lost because real-world conversations do not always fit neatly into predefined fields.
Veeva’s Agentic Call Report is designed to allow compliant free-text capture and use AI to identify commercially relevant information.
Veeva describes this as generating Commercial Evidence, potentially helping organisations identify treatment barriers and other insights that might otherwise remain hidden in individual field interactions.
This could prove particularly valuable at scale.
Imagine hundreds or thousands of field interactions taking place across multiple markets.
Individually, each conversation may contain only a small piece of information.
Collectively, those observations could reveal a much larger pattern.
That is where CRM starts to become something more than a customer database.
It becomes a source of organisational intelligence.
Making Life Easier for the Field Team
A CRM is only valuable if people actually use it.
That is especially important for field teams who may spend much of their working day away from a desk.
Vault CRM supports browser, desktop and mobile environments, with offline functionality designed to keep field users productive even when an internet connection is unavailable.
The platform also integrates with familiar Microsoft tools including Outlook, Teams and OneNote, helping users work within an environment they already understand.
Veeva’s AI capabilities take this further.
The August 2026 Vault CRM 26R2.0 release includes an early-adopter Conversational AI capability that allows users to use voice and text to research accounts, prepare for HCP interactions, plan activities and access workflows.
For field teams, that direction could be significant.
Instead of CRM being another administrative system that representatives have to “feed”, it increasingly becomes an assistant that helps them get work done.
Omnichannel Engagement for HCPs
Modern pharmaceutical engagement does not stop when a sales representative leaves an HCP’s office.
HCPs may interact with pharmaceutical organisations through face-to-face meetings, remote meetings, email, events and digital channels.
Veeva Vault CRM Engage is designed to support compliant digital engagement, including meeting scheduling, remote meetings and communication between field teams and HCPs.
Approved Email and Campaign Manager extend the platform’s capabilities into other commercial and marketing activities.
The advantage is visibility.
Rather than treating every interaction as an isolated event, organisations can build a more complete picture of how an HCP engages with them.
That supports a more coordinated approach to customer engagement.
Veeva Is Not Just About Sales
Another reason Vault CRM stands out is its broader scope.
The platform is designed to connect sales, marketing and medical teams rather than treating CRM purely as a sales-management tool.
That matters because pharmaceutical customer engagement is rarely owned by one department.
A sales representative may have one conversation with an HCP. A medical affairs professional may have another. Marketing may be responsible for digital communications and approved content.
When those activities operate in silos, organisations can end up with duplicated effort and fragmented customer experiences.
Vault CRM’s unified approach is designed to reduce that fragmentation.
What Are Pharmaceutical Companies Saying About Veeva?
This is perhaps one of the strongest parts of Veeva’s proposition.
The company has attracted major pharmaceutical organisations to Vault CRM, including Novo Nordisk, Bayer, Gilead Sciences, Ionis Pharmaceuticals and others.
Novo Nordisk’s Frank Armenante says:
“Vault CRM puts us on a fast track to innovation.”
He also says the company is looking to use Veeva AI to maximise customer engagement while reducing field preparation and data entry.
Bayer’s Vice President of IT Pharma Commercial Global, Ozlem Arisoy, said:
“We are excited to expand our long-standing partnership with Veeva by moving to Vault CRM.”
And in May 2026, Teva Pharmaceuticals announced its global commitment to Vault CRM, with Lavanya Narasimhamurthy, Vice President IT US Commercial and Global Commercial Solutions, saying that Vault CRM would provide the company’s “technical foundation to drive commercial execution.”
These customer commitments matter because they demonstrate that Vault CRM is not merely an emerging technology proposition.
It is being adopted by major life sciences organisations with highly complex commercial environments.
Veeva CRM vs Veeva Vault CRM
There is an important distinction that anyone researching Veeva in 2026 should understand.
Veeva CRM is being replaced by the next-generation Vault CRM platform.
That means older articles describing Veeva CRM as though it were the current product can quickly become outdated.
Vault CRM is intended to provide the next-generation foundation for Veeva’s CRM capabilities, with a stronger emphasis on unified data, embedded AI and the broader Vault platform.
For companies evaluating Veeva today, the focus should therefore be on Vault CRM, not simply the legacy Veeva CRM product.
The transition is already well underway, with more than 150 customers now live on Vault CRM according to Veeva’s August 2026 update.
Who Is Veeva Vault CRM Best For?
Let’s be honest: Veeva is not a CRM for everyone.
If you are a freelancer, small retailer, local service business or two-person consultancy, Veeva would almost certainly be far more CRM than you need.
Its strengths become much more apparent for organisations dealing with:
- Pharmaceutical products
- Biotechnology
- Large commercial and medical teams
- Complex HCP relationships
- Strict regulatory requirements
- Global operations
- Multiple engagement channels
- Large field forces
- Complex account structures
- Extensive customer and interaction data
For these organisations, the cost and complexity of implementing a sophisticated CRM need to be weighed against the potential operational benefits.
But comparing Veeva with a simple small-business CRM is also somewhat misleading.
They are solving very different problems.
The Bottom Line: Is Veeva Worth Considering?
For pharmaceutical and life sciences companies, Veeva has built a compelling proposition.
Vault CRM combines deep industry functionality with customer management, field engagement, compliance, omnichannel communication and increasingly sophisticated AI.
Its biggest strength may be that these capabilities are not being developed in isolation.
They are being brought together on a platform designed specifically for life sciences.
And that is important because the future of pharmaceutical CRM is unlikely to be about simply storing more customer records.
It will be about understanding customers better, connecting teams more effectively, reducing administrative work and turning the enormous amount of information generated in the field into useful intelligence.
Veeva’s move toward agentic CRM suggests that this future is already beginning.
For a pharmaceutical organisation evaluating CRM in 2026, Vault CRM deserves to be on the shortlist.
Not because it is a conventional CRM with a pharmaceutical label attached.
But because it has been designed from the ground up around the realities of life sciences.
A Final Word for Smaller Businesses
Veeva’s sophistication is also its limitation.
A small pharmaceutical consultancy or a small business with relatively straightforward customer relationships may find a platform of this scale unnecessary.
The right CRM is not automatically the one with the most features.
It is the one that fits the organisation’s size, complexity, budget and goals.
For global or enterprise pharmaceutical companies, however, Veeva Vault CRM offers something that generic CRM platforms may struggle to match: a purpose-built environment combining life sciences expertise, compliance, customer engagement, data and AI.
And as pharmaceutical CRM moves increasingly toward AI-assisted, connected and evidence-driven engagement, Veeva is positioning itself firmly at the centre of that transformation.